Archive for April, 2010

Computer Weekly’s top stories in tech! Tax breaks for video gaming, Large Hadron Collider, iPad review!

‘Hermione Way looks over the last week’s top tech news, including Budget tax breaks for video gaming, the latest events at the Large Hadron Collider, and, of course, the iPad, in ComputerWeekly.com’s light-hearted news round-up video.’

From the techxperts: How entrepreneurs should use social networks in their global communication

If you haven’t heard me bigging up business social network Viadeo then you must have been living under a rock in the middle of the desert somewhere. Bigger than LinkedIn in France and China, Viadeo are also committed to helping the next generation of startup entrepreneurs by sponsoring events like Global Twestival. They  have also enabled the Techfluff.tv crew to report on many events from the European tech scene including Launch48 and most recently SXSW Interactive in Texas. Besides enabling us to give all our coverage at SXSW we also asked the tech experts ‘How should entrepreneurs be using social networks to communicate globally?’ .  Thanks for supporting the European entrepreneurial community Viadeo, If you’re watching hope you land some good tips and advice!

Geek Porn, April Fools and Procrastination

Some great videos around today:

Geek Porn: iPad unpacking:

April fools: Google translate for animals!

Procrastination: Tales of a mere existence.

Pharma company Boehringer launches €100 Million Global Venture Fund to invest in Biotech and science.

Pharmaceutical company Boehringer Ingelheim this week announced the launch of its corporate  € 100 Million venture capital fund, the Boehringer Ingelheim Venture Fund (BIVF), with the first investments being made in 2010.

The BIVF aims to invest in Biotech and Start-up companies that provide ground-breaking therapeutic approaches and technologies to help drive innovation in medical science. These may include – but are not limited to – new therapeutic concepts including stem cells and RNA silencing as well as new generation vaccines, new generation protein or antibody technologies, new molecular targets and/or first-in-class lead compounds. Disease-related biomarkers would be an additional area of focus.

“Our investments will extend beyond the current therapeutic area focus of Boehringer Ingelheim and our existing therapeutic approaches and technologies.” says Prof. Andreas Barner, Chairman of the Board of Managing Directors at Boehringer Ingelheim. “We have extensive drug discovery expertise and can take advantage of knowledge and experience available within our global organisation, but we are aware that there is an entire landscape of novel therapeutic ideas and potentially breakthrough technologies that need to be supported for future patients’ benefit.”

Paralyzed Graffiti Artist Draws With His Eyes

It is a low-cost eye-tracking apparatus & custom software that allows graffiti writers and artists with paralysis resulting from Amyotrophic lateral sclerosis to draw using only their eyes.The EyeWriter project is an ongoing collaborative research effort to empower people who are suffering from ALS with creative technologies.